Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma. by Frisch, M. et al.
British Joumal ofCancer(1998) 78(11), 1534-1538
© 1998 Cancer Research Campaign
Benign anal lesions, inflammatory bowel disease and
risk for high-risk human papillomavirus-positive and
-negative anal carcinoma
M Frisch', B Glimelius2, AJC van den Brule3, J Wohifahrt1, CJLM Meijer3, JMM Walboomers3, H-O Adami45
and M Melbye1
'Department of Epidemiology Research, Danish Epidemiology Science Centre, Statens Serum Institut, Copenhagen, Denmark; 2Department of Oncology,
University Hospital, Uppsala, Sweden; 3Department of Pathology, Section for Molecular Pathology, University Hospital Vrije Universiteit, Amsterdam,
The Netherlands; 4Department of Medical Epidemiology, Karolinska Institute, Stockholm, Sweden; 5Department of Epidemiology and Harvard Centerfor
Cancer Prevention, Harvard University, Boston, MA, USA
Summary A central role in anal carcinogenesis of high-risk types of human papillomaviruses (hrHPV) was recently established, but the
possible role of benign anal lesions has not been addressed in hrHPV-positive and -negative anal cancers. As part of a population-based
case-control study in Denmark and Sweden, we interviewed 417 case patients (93 men and 324 women) diagnosed during the period
1991-94 with invasive or in situ anal cancer, 534 patients with adenocarcinoma of the rectum and 554 population controls. Anal cancer
specimens (n = 388) were tested for HPV by the polymerase chain reaction. Excluding the 5 years immediately before diagnosis, men, but not
women, with anal cancer reported a history of haemorrhoids [multivariate odds ratio (OR) 1.8; 95% confidence interval (Cl) 1.04-3.2] and
unspecific anal irritation (OR 4.5; Cl 2.3-8.7) significantly more often than controls. Women with anal cancer did not report a history of benign
anal lesions other than anal abscess to any greater extent than controls, but they had used anal suppositories more often (OR 1.5; Cl
1.1-2.0). Patients with hrHPV in anal cancer tissue (84%) and those without (16%) reported similar histories of most benign anal lesions, but
anal fissure or fistula was more common among hrHPV-positive cases. Ulcerative colitis and Crohn's disease, reported by <11% of study
participants, were not associated with anal cancer risk. The higher proportion of hrHPV-positive anal cancers among case patients with anal
fissure or fistula suggests that such mucosal lesions may provide direct viral access to basal epithelial layers. Since risk associations with
benign anal lesions in men may be confounded by unreported sexual behaviour, and since risk associations in women were generally
negative, it seems unlikely that benign anal lesions act as promoters in hrHPV-associated anal carcinogenesis. Moreover, benign anal lesions
appear not to be linked to an alternative, hrHPV-unassociated causal pathway to anal cancer. Ulcerative colitis and Crohn's disease were not
supported as causal factors for anal cancer.
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The incidence of epidermoid anal cancer, a rare neoplasm of the
anal canal and perianal skin, has increased considerably during the
past decades (Goldman et al, 1989; Frisch et al, 1993; Melbye et
al, 1994). It has been shown that anal cancer has a sexually trans-
mitted aetiology (Daling et al, 1987; Holly et al, 1989; Frisch et al,
1997). Substantial evidence now points to the causal involvement
of certain high-risk types of human papillomaviruses (hrHPV),
notably HPV type 16, in the majority of anal cancers (Holm et al,
1994; Frisch et al, 1997). One case-control study (Holly et al,
1989) provided data that were interpreted as supportive of the
old belief that anal inflammation predisposes to anal cancer
(Brofeldt, 1927; Buckwalter and Jurayj, 1957). However, another
case-control study (Holmes et al, 1988) and two subsequent
cohort studies did not accord with this view (Frisch et al, 1994; Lin
et al, 1995). Based on data from a nationwide case-control study
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in Denmark and Sweden, we attempted to re-evaluate the associa-
tion between benign anal lesions and the risk for hrHPV-positive
and -negative anal cancer.
MATERIALS AND METHODS
We identified all incident cases of histologically verified invasive
and in situ anal and rectal epidermoid carcinoma (hereafter
referred to as anal cancer) in Denmark and Sweden for the period
1991-94 (and five cases from 1995) as described in detail else-
where (Frisch et al, 1997). Two control groups were included: one
consisting of patients with adenocarcinoma of the rectum (cancer
controls) and another consisting of population controls drawn
from national population registers. Each control group was
frequency matched within each country on sex and age (±5 years)
and for cancer controls, on the year ofdiagnosis.
Data collection
Participants were interviewed by telephone using a structured
questionnaire covering a large number of possible risk factors for
anal cancer. A separate report gives a detailed analysis of sexual
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Table 1 Demographic characteristics of participants in the Danish-Swedish anal cancer case-control study, 1991-94
Women Men
Anal Rectal Population Anal Rectal Population
cancer cancer controls cancer cancer controls
casesa controls casesa controls
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Participation rateb 79% 78% 61% 73% 71% 60%
Nationality
Danish 157 (48) 160 (47) 174 (50) 51 (55) 99 (52) 114 (56)
Swedish 167 (52) 183 (53) 175 (50) 42 (45) 92 (48) 91 (44)
Age at diagnosisc (years)
<40 29 (9) 13 (4) 46 (13) 6 (6) 5 (3) 17 (8)
40-49 56 (17) 48 (14) 79 (23) 13 (14) 28 (15) 37 (18)
50-59 69 (21) 91 (27) 46 (13) 25 (27) 44 (23) 38 (19)
60-69 73 (23) 67 (20) 91 (26) 18 (19) 30 (16) 42 (20)
70-79 68 (21) 92 (27) 69 (20) 26 (28) 67 (35) 53 (26)
>80 29 (9) 32 (9) 18 (5) 5 (5) 17 (9) 18 (9)
Years at school
<10 221 (68) 244 (71) 214 (61) 65 (70) 151 (79) 139 (68)
.10 103 (32) 99 (29) 135 (39) 28 (30) 40 (21) 66 (32)
Post-school education
None 118 (36) 131 (38) 100 (29) 24 (26) 61 (32) 48 (23)
Short (<3 years) 180 (56) 180 (52) 195 (56) 53 (57) 102 (53) 112 (55)
Long (>3 years) 26 (8) 32 (9) 54 (15) 16 (17) 28 (15) 45 (22)
aFemale cases comprised 262 women with invasive and 62 with in situ anal cancer; male cases comprised 87 men with invasive and six with in situ anal cancer.
bParticipation rates were calculated as the proportion of invited subjects who were interviewed. cA pseudo-year of diagnosis was assigned to population controls
according to the distribution of year of diagnosis among patients of the same sex with anal cancer.
behaviour and venereal diseases and their association with the risk
for anal cancer (Frisch et al, 1997). All interviews were conducted
by medically trained interviewers who were unaware of the
specific study hypotheses. The study was approved by the scien-
tific ethics committees ofboth participating countries.
We interviewed a total of417 patients with anal cancer (93 men
and 324 women), 534 cancer controls (191 men, 343 women) and
554 population controls (205 men, 349 women). Participation
rates and selected characteristics for the study participants are
presented in Table 1.
Tissue analyses
Paraffin-embedded anal cancer specimens were collected from
over 60 pathology laboratories in Denmark and Sweden.
Specimens were subjected to general primer GPS+/6+ mediated
polymerase chain reaction (PCR) analyses for the presence of
most, if not all, mucosotropic human papillomaviruses as
described elsewhere (Frisch et al, 1997; Jacobs et al, 1997). For
the purpose of the present analysis, tumours were divided into
those that were positive to one or more of 14 distinct hrHPV types,
i.e. types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68,
and those that were negative to each ofthese hrHPV types.
Statistical methods
Men and women were analysed separately. Univariate odds ratios
(ORs) were calculated with adjustment only for age (<40, 40-49,
50-59, 60-69, 70-79, .80 years), country (Denmark, Sweden)
and yearofdiagnosis (1991, 1992, 1993, 1994-95). A pseudo-year
ofdiagnosis was attributed to population controls according to the
distribution of year of diagnosis among cases of the same sex.
Multivariate logistic regression analyses were performed to iden-
tify independent predictors of the risk. Because univariate ORs
obtained with the two control groups were generally similar, and
because the distribution of major sexual and venereal confounder
variables was previously found to be similar in the two control
groups (Frisch et al, 1997), we combined them to increase statis-
tical power in the multivariate analyses. The multivariate OR for
each variable was adjusted for potential confounding by age at
diagnosis (<40, 40-49, 50-59, 60-69, 70-79, >80 years), country
(Denmark, Sweden), year of diagnosis (1991, 1992, 1993,
1994-95), years at school (<10, >10), years ofpost-school educa-
tion (none, <3, >3), smoking status (current, former, never) and for
major sexual and venereal factors. In men, sexual and venereal
factors included marital status (ever vs nevermarried) and lifetime
number of female partners (0, 1, 2 or 3, 4-9, .10) as well as for
anogenital warts (yes/no), gonorrhoea (yes/no) and syphilis or
hepatitis (yes/no). In women, sexual and venereal factors included
marital status (ever vs never married), lifetime number of male
partners (0, 1, 2 or 3, 4-9, .10), practice of anal intercourse
(yes/no), anogenital warts (yes/no), gonorrhoea (yes/no) and
history of a sexually transmitted disease in the male partner
(yes/no). All regression analyses were performed using likelihood
ratio tests by means of the GENMOD procedure in SAS. In tests
for trend, we treated categorized continuous variables as contin-
uous variables with the median in each category as the category
value (SAS Institute Inc., 1996).
Finally, we performed a set of analyses within the subgroup of
84 men and 304 women with anal cancer for whom we had
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Table 2 Benign anal lesionsa and anal suppository use, odds ratios (anal cancer cases vs all controls) and 95% confidence intervals (Cl), Danish-Swedish
anal cancer case-control study, 1991-94
Women Men
Anal Rectal Population Anal Rectal Population
cancer cancer controls Univariateb Multivariateb cancer cancer controls Univariateb Multivariateb
cases controls odds ratio odds ratio cases controls odds ratio odds ratio
No. (%) No. (%) No. (%) (95% Cl) (95% Cl) No. (%) No. (%) No. (%) (95% Cl) (95% Cl)
Anal fissure/fistula 39 (13) 53 (16) 50 (15) 0.8 (0.6-1.2) 0.8 (0.5-1.2) 21 (23) 20 (11) 29 (15) 2.2 (1.2-3.9) 1.9 (0.97-3.7)
Haemorrhoids 128 (41) 153 (47) 148 (44) 0.8 (0.6-1.1) 0.8 (0.6-1.1) 43 (48) 74 (40) 74 (37) 1.6 (0.97-2.5) 1.8 (1.04-3.2)
Anorectal abscess 11 (3) 7 (2) 2 (1) 2.8 (1.1-6.9) 3.0 (1.1-8.3) 8 (9) 11 (6) 15 (7) 1.3 (0.6-3.0) 1.1 (0.4-2.9)
Anorectal prolapse 12 (4) 17 (5) 17 (5) 0.7 (0.4-1.4) 0.7 (0.3-1.4) 6 (7) 3 (2) 5 (2) 3.6 (1.2-11.0) 2.9 (0.8-10.4)
Unspecific anal irritationc 26 (8) 26 (8) 19 (5) 1.3 (0.8-2.2) 1.1 (0.6-1.9) 28 (30) 19 (10) 22 (11) 3.8 (2.2-6.8) 4.5 (2.3-8.7)
Anal suppository use 124 (38) 103 (30) 112 (32) 1.4 (1.1-1.9) 1.5 (1.1-2.0) 36 (39) 66 (35) 62 (30) 1.4 (0.8-2.2) 1.1 (0.6-2.0)
aOnly anal lesions that preceded the time of diagnosis (or a similar point in time for population controls) by >5 were considered. bUnivariate odds ratios are
adjusted for age (<40, 40-49, 50-59, 60-69, 70-79, >80 years), year of diagnosis (1991, 1992, 1993, 1994-95) (pseudo-year for population controls) and
country (Denmark, Sweden). Multivariate odds ratios are adjusted for age (<40, 40-49, 50-59, 60-69, 70-79, .80 years), year of diagnosis (1991, 1992, 1993,
1994-95), country (Denmark, Sweden), years at school (<10, >10), years of post-school education (none, <3, >3), smoker status (current, former, never), and a
number of sexual and venereal variables. In men, sexual and venereal variable included marital status (ever married, never married), lifetime number of female
partners (0, 1, 2 or 3, 4-9, .10), anogenital warts (yes/no), gonorrhoea (yes/no) and syphilis or hepatitis (yes/no). In women, sexual and venereal variables
included marital status (ever married, never married), lifetime number of male partners (0, 1, 2 or 3, 4-9, >10), anal intercourse (yes/no), anogenital warts
(yes/no), gonorrhoea (yes/no) and history of a sexually transmitted disease in the spouse (yes/no). Respondents who did not report a history of the anal
inflammatory lesion in question at least 5 years before the time of diagnosis (or a similar point in the time for population controls) or the use of anal
suppositories served as the reference group. cUnspecific anal irritation was present when respondents reported a history of anal eczema, anal pruritus or anal
moniliasis >5 years before the time of diagnosis (or a similar point in the time for population controls).
performed successful PCR analyses for hrHPV. Possible differ-
ences in the distribution of the anal lesions studied between anal
cancers that were hrHPV positive (272 women, 55 men) and nega-
tive (32 women, 29 men) were evaluated by means of likelihood
ratio X2-test or Fisher's exact test (two-tailed).
RESULTS
We considered only anal lesions that preceded the time of diag-
nosis by more than 5 years to minimize problems in distinguishing
these lesions from early symptoms of anorectal cancer. Except for
anal abscess, a rare event reported by 3% of female cases (n = 1)
and 1% of female controls (n = 9), a history ofbenign anal lesion
was not more common among women with anal cancer (Table 2).
In men, however, fissure or fistula, haemorrhoids, anorectal
prolapse and unspecific anal irritation - but not anal abscess -
were all associated with increased risk (Table 2). Exclusion of men
who reported any homosexual experience (n = 14, all cases) did
not substantially change estimates of the relative risk. In this
restricted analysis among men, multivariate associations with anal
fissure or fistula (OR = 1.7; 95% CI 0.8-3.5) and with anorectal
prolapse (OR = 2.3; 95% CI 0.6-9.2) became slightly weaker, but
associations with haemorrhoids (OR = 2.0; 95% CI 1.1-3.6) and
unspecific anal irritation (OR = 4.7; 95% CI 2.4-9.5) remained
significantly above unity. A history ofinflammatory bowel disease
was not associated with the risk for anal cancer in either sex. Only
six women (univariate OR = 0.4) and four men (univariate OR =
1.5) reported a history of ulcerative colitis, and four women had
Crohn's disease (univariate OR = 0.7). Women, but not men, with
anal cancer were significantly more likely to report the use of
anal suppositories than controls (multivariate OR = 1.5; 95% CI
1.1-2.0) (Table 2).
We subsequently examined histories of benign anal lesions
among case patients stratified according to the viral status of the
anal cancer (Table 3). Among case women who reported a history
of anal fissure or fistula, all patients who had tumour tissue exam-
ined (n = 35) were hrHPV positive. Among case women without
prior anal fissure or fistula (n = 219), only 88% were hrHPV
postive (Fisher's test, P = 0.02). A similar tendency was present
among men; among male cases reporting a history of anal fissure
or fistula (n = 15) 83% were hrHPV positive vs 62% among male
cases with no prior history of anal fissure or fistula (Fisher's test,
P =0.10). A comparison ofanal cancerpatients with and without a
history of anorectal prolapse or, among men, anorectal abscess
showed that case patients with such prior anal lesions were hrHPV
positive more often, although not significantly so, than those
without such prior lesions. Detectable hrHPV in the anal cancer
was equally present in case patients with and without histories of
haemorrhoids, unspecific anal irritation or, among women,
anorectal abscess (Table 3).
Male cases who had used anal suppositories had detectable
hrHPV in their tumour tissue more often than those who did not
report such use (P = 0.03), whereas the majority of female cases,
irrespective ofanal suppository use, were hrHPV positive (Table 3).
DISCUSSION
Infection with hrHPV is now considered necessary for the devel-
opment of most, if not all, squamous cell cancers of the uterine
cervix (International Agency for Research on Cancer, 1995; Shah,
1997). There is also mounting evidence that the same types of
HPV, particularly type 16, are involved in the aetiology of most
anal epidermoid carcinomas (Daling et al, 1992; Holm et al, 1994;
Frisch et al, 1997). However, other factors involved in the devel-
opment ofanal cancer are poorly characterized. Such factors could
either act independently or modify the oncogenic effect ofhrHPV.
For decades anal inflammation has been considered to be such a
contributing factor (Brofeldt, 1927; Buckwalter and Jurayj, 1957),
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Table 3 Benign anal lesionsa and anal suppository use in patients with high-risk human papillomavirusb-positive (hrHPV+) and -negative (hrHPV-) anal cancer,
Danish-Swedish anal cancer case-control study, 1991-94
Women with anal cancer
No. (%)
hrHPV+ hrHPV- (PLvaluec)
Men with anal cancer
No. (%)
hrHPV+ hrHPV- (PLvaluec)
Anal fissure/fistula
Yes
No
Haemorrhoids
Yes
No
Anorectal abscess
Yes
No
Anorectal prolapse
Yes
No
Unspecific anal irritationd
Yes
No
Anal suppository use
Yes
No
35 (100) 0 (0)
219 (88) 31 (12)
107 (90) 12 (10)
156 (89) 20 (11)
10 (91) 1 (9)
256 (89) 31 (11)
11 (100) 0 (0)
260 (89) 31 (11)
23 (92) 2 (8)
244 (89) 29 (11)
104 (90) 12 (10)
168 (89) 20 (11)
15 (83)
40 (62) (0.02)
3 (17)
25 (38)
25 (64) 14 (36)
29 (67) 14 (33) (0.73)
6 (75)
(1.00) 49 (64)
2 (25)
27 (36)
5 (100) 0 (0)
48 (63) 29 (37) (0.61)
16 (64) 9 (36)
38 (66) 20 (34) (1.00)
24 (80)
(0.94) 31 (57)
6 (20)
23 (43)
aOnly anal lesions that preceded the time of anal cancer diagnosis by >5 years were considered. bHigh-risk HPV positive anal cancers were positive to one or
more of HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68. cStatistical tests used were Fisher's exact test (two-tailed) when there were <5
observations in one or more cells; otherwise likelihood ratio X2-test was used. dUnspecific anal irritation was present when respondents reported a history of anal
eczema, anal pruritus or anal moniliasis >5 years before the time of diagnosis.
and results from one case-control study have encouraged this
belief (Holly et al, 1989). However, there are inconsistencies
between the few previous studies as to what specific anal lesions
are risk factors. Holly et al, (EA Holly personal communication)
found increased risks associated with haemorrhoids and anal
fissure/fistula in a combined analysis of women and heterosexual
men, but unlike for women in the present study, there was no asso-
ciation with anorectal abscess in either sex. Another case-control
study found no significant association with fissures, fistulae or
haemorrhoids and the risk for anal cancer in women (Holmes et al,
1988), while a third study did not present data on benign anal
lesions (Daling et al, 1987).
One limitation of our and previous case-control studies is that
self-reported anal lesions may be subject to differential misclassi-
fication. It is well established that early symptoms of anal cancer
may be difficult to distinguish clinically from haemorrhoids and
other benign conditions (Jensen et al, 1987). We sought to mini-
mize this potential bias by disregarding the 5 years before diag-
nosis. As in a previous study (Holly et al, 1989), we observed a
number of associations with benign anal lesions, but the lack of
consistency between the two sexes detracts from the idea of
causality, because it is not plausible that benign anal lesions are
carcinogenic only in one gender. Anal abscess was associated with
risk only in women, whereas a history of haemorrhoids increased
the risk only in men. Moreover, it is not conceivable that unspe-
cific anal irritation due to eczema, pruritus or moniliasis in the anal
region should be a genuine carcinogenic factor in men only.
Rather, we speculate that anal irritation and other benign anal
lesions may be linked to one of the major risk factors for anal
cancer in men for which it is possible that accurate information has
not been obtained from all participants. We have recently shown
strong statistical associations between a number of sensitive vari-
ables, including the number of partners ofthe opposite sex and the
practice of heterosexual anal intercourse (Frisch et al, 1997).
However, not even one out of 396 male controls reported ever
having engaged in homosexual activity. Consequently, homo-
sexual experience may be underestimated in the present study
because of underreporting and/or self-selection among partici-
pants. Underreporting may create spurious associations between
anal cancer and other, less sensitive, variables that are associated
with homosexual activity. As traumatic and inflammatory anal
complaints are reported to be common in homosexual men (Kazal
et al, 1976), we suggest that confounding by unreported homo-
sexual experience may
- at least in part
- account for the signifi-
cant associations observed between benign anal lesions and anal
cancer in men.
The idea that benign anal lesions or the inflammatory process
that may accompany such lesions is involved in the causation of
anal cancer was also challenged in two recent cohort studies. A
follow-up study of 68 000 patients hospitalized in Denmark for
haemorrhoids, fissures, fistulae or anal abscesses did not support a
causal association. The risk for anal cancer was elevated only in
the first few years, but not 5 or more years after the benign anal
lesion (Frisch et al, 1994). These temporal associations were
confirmed in a subsequent study (Lin et al, 1995). The absence of
any convincing link between benign anal lesions and the risk for
anal cancer in women (who constituted 78% ofthe case patients in
this study), and the likelihood of a non-causal explanation for the
statistical associations observed in men, in combination with the
results from previous studies (Holmes et al, 1988; Frisch et al,
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1994; Lin et al, 1995), argue against anal inflammation as a
genuine aetiological factor.
Nevertheless, in both men and women, we observed a higher
proportion of hrHPV-positive anal cancers among patients who
reported a history of anal fissure or fistula. Although we cannot
rule out the possibility that hrHPV-infected anal mucosa might be
more prone to the development of crack sores, we suggest the
reverse causal pathway, namely that fissures or fistulae may
provide direct viral access to basal mucosal layers. A similar
mechanism has been proposed for hrHPV-related cervical
neoplasia (Schneider and Koutsky, 1992).
In the aetiology ofvulval cancer, hrHPV appears to be involved
mainly in cancers histologically categorized as either warty or
basaloid carcinoma; for keratinizing squamous cell carcinomas
that are not linked to hrHPV to the same extent, unspecific
dystrophic or inflammatory vulval lesions may be involved (Toki
et al, 1991; Trimble et al, 1996). By analogy, we examined
whether anal cancers in which hrHPV was not detected were
linked to benign anal lesions and unspecific irritation more firmly
than anal cancers testing positive to hrHPV. This was not the case
in as much as anal cancer patients reporting such prior anal
complaints contained hrHPV DNA in their tumour to a similar or
even greater extent than anal cancer patients without prior anal
lesions. Moreover, in accordance with other investigations
(Holmes et al, 1988; Frisch et al, 1994), the present study failed to
support causal speculations based on anecdotal reports of anal
cancer in patients with large bowel inflammatory diseases, notably
Crohn's disease (Slater et al, 1984).
In conclusion, we suggest that anal fissure or fistula may facili-
tate viral access to basal epithelial layers. However, benign anal
lesions are unlikely candidates both as promoters in hrHPV-related
anal carcinogenesis and as causal factors in hrHPV-unassociated
anal cancer. Ulcerative colitis and Crohn's disease were not
supported as causal factors for anal cancer.
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